Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Pathogenesis of urinary tract infections with normal female anatomy
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies  Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.
ZIKA App – A great resource from the World Health Organization (WHO)
Increase in sexually transmitted infections during Europride 2013 in Marseille, France  Grégory Dubourg, Philippe Colson, Catherine Tamalet, Pierre Edouard.
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Brian J Coburn, David J Gerberry, Sally Blower 
Germany must invest in its global health academic workforce
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
Controlling Ebola: key role of Ebola treatment centres
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Infections related to totally implantable venous-access ports
Herpes zoster in non-hospitalized children
Long-term effects of hormone replacement therapy
Underestimate of annual malaria imports to Canada – Author reply
Ebola superspreading The Lancet Infectious Diseases
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
When less is more: how many doses of PCV are enough?
Lauren M Gardner, Nan Chen, Sahotra Sarkar 
Changing trends of neglected tropical diseases in China
Carriage of β-lactamase-producing Enterobacteriaceae by Chinese travellers  Lan-Lan Zhong, Nicole Stoesser, Yohei Doi, Cong Shen, Xi Huang, Guo-Bao Tian 
Volume 18, Issue 4, Pages (October 2015)
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Mapping HIV epidemics in sub-Saharan Africa with use of GPS data
Rising food insecurity in Europe
Finding undiagnosed leprosy cases
Physiological hazards of flight at high altitude
Results from a mathematical model for human monocytic ehrlichiosis
Can plagues be predicted, prevented?
Prevalence of mycoplasma encephalitis
Finding undiagnosed leprosy cases
Disease and stigma The Lancet Volume 354, (December 1999)
Low risk of a sexually-transmitted Zika virus outbreak
Arnaud Chiolero  The Lancet Public Health 
HIV myths should not be resuscitated
Challenges to eliminate rabies virus infection in China by 2020
The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses  W.G. Melsen, M.C.J. Bootsma, M.M. Rovers,
DEPARTMENT OF ERROR The Lancet Volume 362, Issue 9385, (August 2003)
Modelling the effect of early detection of Ebola
Ngoc Minh Pham, Chung Thanh Nguyen, Colin W Binns, Andy H Lee 
Community-based care of Ebola virus disease in west Africa
MERS in South Korea and China: a potential outbreak threat?
Assessment of herd immunity from human papillomavirus vaccination
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Metabolic mediators of body-mass index and cardiovascular risk
One Health strategies for rabies control in rural areas of China
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Errata The Lancet Infectious Diseases
Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer 
Telling it like it isn't: truth and lies in a post-9/11 world
Thank God for Richard Dawkins?
Thank you to our diverse (but not diverse enough) reviewers
Volume 17, Issue 2, Pages (February 1950)
Artefenomel: a promising new antimalarial drug
Procalcitonin as a diagnostic marker for sepsis
Costs of eliminating HIV in South Africa have been underestimated
The 2009 influenza pandemic
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Beware: shifting paradigms ahead
Dengue pre-vaccination screening and positive predictive values
Ebola control: rapid diagnostic testing
Sputum culture conversion in new TB regimens
A 12 year outbreak of scarlet fever in Singapore
Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44
Sickle cell disease: a new era
Presentation transcript:

Predicting the potential for within-flight transmission and global dissemination of MERS  Brian J Coburn, Sally Blower  The Lancet Infectious Diseases  Volume 14, Issue 2, (February 2014) DOI: 10.1016/S1473-3099(13)70358-X Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Within-flight transmission of MERS-CoV Each probablity distribution is based on 10 000 scenarios with different levels of index-case infectivity. Red lines represent predictions for which the index case travels by economy, and blue lines represent travel by first class. Solid lines represent predictions for a 5 h flight and dotted lines show predictions for a 13 h flight. (A) The predicted number of infections caused by one infectious case of MERS during a long-distance flight. (B) The predicted per-passenger risk of infection due to one infectious case of MERS during a long-distance flight. The Lancet Infectious Diseases 2014 14, DOI: (10.1016/S1473-3099(13)70358-X) Copyright © 2014 Elsevier Ltd Terms and Conditions